Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Todd C. Davis | Director | $15.3M | Jul 2, 2025 | ||
Ligand Pharmaceuticals Inc | 10%+ Owner | $15M | Jul 1, 2025 | ||
Motif Pharmaceuticals Ltd. | 10%+ Owner | $2.26M | Feb 15, 2024 | ||
Boswell Prayer Ltd. | 10%+ Owner | $2.21M | Feb 15, 2024 | ||
Aperture Healthcare Ventures Ltd. | 10%+ Owner | $2.05M | Feb 15, 2024 | ||
AME Equities LLC | 10%+ Owner | $1.69M | Feb 15, 2024 | ||
Ezra Friedberg | Director | $1.48M | Jul 2, 2025 | ||
Richard Malamut | Director | $199K | Jul 2, 2025 | ||
Francis Knuettel II | CFO, Treas & Secty | $114K | Jul 2, 2025 | ||
Chia-Lin Simmons | Director | Apr 11, 2025 | |||
Eric Lang | Chief Medical Officer | Jun 14, 2024 | |||
Richard Baxter | Director | Jul 2, 2025 | |||
Peter Greenleaf | Director | Jul 2, 2025 | |||
Scott M. Plesha | CEO and President, Director | Jul 2, 2025 | |||
Sai Rangarao | Chief Commercial Officer | Jul 2, 2025 | |||
Matthew Pauls | Director | Jul 2, 2025 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|